Gary Patou
Gary Patou's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link to…
Insider buying and selling since 2013
Gary Patou bought shares on the open market in 2017, and has not bought since 2017 across 2 companies. Sales in 5 of the 14 years since 2013.
Gary Patou reported 2 open-market purchases and 20 sales since 2013; purchases in 2017.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | 2×2 trades |
| 2023 | — | 5×5 trades |
| 2022 | — | 2×2 trades |
| 2017 | 2×2 trades | — |
| 2014 | — | 5×5 trades |
| 2013 | — | 6×6 trades |
Insider at 2 companies
- Xenon Pharmaceuticals XENE2017–2024 · 2 purchases, 9 sales
- Pacira BioSciences, Inc. PCRX2013–2014 · 0 purchases, 11 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Gary Patou's trades
Has Gary Patou bought shares on the open market?
Gary Patou bought shares on the open market in 2017, and has not bought since 2017 across 2 companies. Sales in 5 of the 14 years since 2013.
When did Gary Patou last buy or sell shares?
In SEC filings since 2013: the latest open-market purchase is from 2017; the latest open-market sale is from 2024.
Which companies has Gary Patou traded as an insider?
2 companies: Xenon Pharmaceuticals (XENE, 2017–2024), Pacira BioSciences, Inc. (PCRX, 2013–2014).